EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1

Manijeh Mahdavi, Karine Prévost, Philippe Balthazar, Isabelle Fisette-Paul Hus, Élise Duchesne, Nicolas Dumont, Valérie Gagné-Ouellet, Cynthia Gagnon, Isabelle Laforest-Lapointe, Eric Massé

Computational and Structural Biotechnology Journal · 2024-12 · 23 · 2097-2108

DOI: 10.1016/j.csbj.2024.05.009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Computational and Structural Biotechnology Journal, online erschienen am 09.05.2024. Verfasst von Manijeh Mahdavi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Functional Genomics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, QC J1E 4K8, Canada. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Genome Quebec, CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myotonic dystrophy type 1 (DM1) is a rare autosomal dominant genetic disorder. Although DM1 is primarily characterized by progressive muscular weakness, it exhibits many multisystemic manifestations, such as cognitive deficits, cardiac conduction abnormalities, and cataracts, as well as endocrine and reproductive issues. Additionally, the gastrointestinal (GI) tract is frequently affected, encompassing the entire digestive tract. However, the underlying causes of these GI symptoms remain uncertain, whether it is biomechanical problems of the intestine, involvement of bacterial communities, or both. The primary objective of this study is to investigate the structural changes in the gut microbiome of DM1 patients. To achieve this purpose, 35 patients with DM1 were recruited from the DM-Scope registry of the neuromuscular clinic in the Saguenay–Lac-St-Jean region of the province of Québec, Canada. Stool samples from these 35 patients, including 15 paired samples with family members living with them as controls, were collected. Subsequently, these samples were sequenced by 16S MiSeq and were analyzed with DADA2 to generate taxonomic signatures. Our analysis revealed that the DM1 status correlated with changes in gut bacterial community. Notably, there were differences in the relative abundance of Bacteroidota, Euryarchaeota, Fusobacteriota, and Cyanobacteria Phyla compared to healthy controls. However, no significant shift in gut microbiome community structure was observed between DM1 phenotypes. These findings provide valuable insights into how the gut bacterial community, in conjunction with biomechanical factors, could potentially influence the gastrointestinal tract of DM1 patients.

Schlagwörter

Stichwörter der Autor:innen

Bacterial communitiesDM1Gastrointestinal symptomsGut microbiotaMicrobiomeMyotonic Dystrophy type 1

Autor:innen und Institutionen

  • Department of Biochemistry and Functional Genomics, Faculty of Medicine and Health Sciences, Université de Sherbrooke, QC J1E 4K8, Canada.
  • Department of Rehabilitation, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.
  • Physiotherapy teaching unit, Université du Québec à Chicoutimi, Chicoutimi, G7H 2B1, Canada.
  • School of Rehabilitation, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Department of Biology, Faculty of Sciences, Université de Sherbrooke, QC J1E 4K8, Canada.

Förderung

  • Genome Quebec
  • CIHR

Zitieren

APA

Mahdavi, M., Prévost, K., Balthazar, P., Hus, I. F., Duchesne, É., Dumont, N., Gagné-Ouellet, V., Gagnon, C., Laforest-Lapointe, I., & Massé, E. (2024). Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1. Computational and Structural Biotechnology Journal, 23, 2097-2108. https://doi.org/10.1016/j.csbj.2024.05.009

Vancouver

Mahdavi M, Prévost K, Balthazar P, Hus IF, Duchesne É, Dumont N, et al. Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1. Computational and Structural Biotechnology Journal. 2024;23:2097-2108. doi:10.1016/j.csbj.2024.05.009

BibTeX
@article{Mahdavi2024,
  author = {Mahdavi, Manijeh and Prévost, Karine and Balthazar, Philippe and Hus, Isabelle Fisette-Paul and Duchesne, Élise and Dumont, Nicolas and Gagné-Ouellet, Valérie and Gagnon, Cynthia and Laforest-Lapointe, Isabelle and Massé, Eric},
  title = {Disturbance of the human gut microbiota in patients with Myotonic Dystrophy type 1},
  journal = {Computational and Structural Biotechnology Journal},
  year = {2024},
  volume = {23},
  pages = {2097--2108},
  doi = {10.1016/j.csbj.2024.05.009}
}
Kostenlos starten →